Vista Finance, LLC Outlook Therapeutics, Inc. Transaction History

Vista Finance, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.0 - $1.35 $59,975 - $80,966	-59,975 Reduced 21.6%	217,640 $237,000
Q4 2022 Feb 09, 2023	SELL	$0.87 - $1.33 $104,347 - $159,520	-119,940 Reduced 30.17%	277,615 $299,000
Q3 2022 Nov 14, 2022	SELL	$1.02 - $1.26 $635,271 - $784,746	-622,815 Reduced 61.04%	397,555 $485,000
Q2 2022 Aug 05, 2022	BUY	$0.91 - $2.01 $33,419 - $73,817	36,725 Added 3.73%	1,020,370 $1.04 Million
Q1 2022 Apr 26, 2022	BUY	$1.22 - $2.03 $1.2 Million - $2 Million	983,645 New	983,645 $1.75 Million

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $520M
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Vista Finance, LLC, based on Form 13F filings with the SEC.

Stay updated on Vista Finance, LLC with notifications on news.